| Schedule of Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets |
The fair values of outstanding derivative instruments are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of
June 30, 2025 | | As of
June 30, 2024 | | Instrument | | Balance Sheet Location | Asset | | Liability | | Asset | | Liability | | Derivatives designated as hedges: | | | | | | | | | | | Cash flow hedge | | Prepaid expenses and other current assets (Accounts payable and accrued liabilities) | $ | 2,068 | | | $ | — | | | $ | — | | | $ | (828) | | | Net investment hedge | | Prepaid expenses and other current assets (Accounts payable and accrued liabilities) | 124 | | | (161,304) | | | 654 | | | (88,186) | | | Total derivatives designated as hedges: | | | 2,192 | | | (161,304) | | | 654 | | | (89,014) | | | | | | | | | | | | | Derivatives not designated as hedges: | | | | | | | | | | | Cross currency swap contracts | | Prepaid expenses and other current assets (Accounts payable and accrued liabilities) | 792 | | | (114,506) | | | 1,473 | | | (70,220) | | | Total derivatives not designated as hedges: | | | 792 | | | (114,506) | | | 1,473 | | | (70,220) | | | Total derivatives | | | $ | 2,984 | | | $ | (275,810) | | | $ | 2,127 | | | $ | (159,234) | |
The effects of gains (losses) from derivative instruments on our Consolidated Statements of Income is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | Instrument | | Income Statement Location | | 2025 | | 2024 | | 2023 | | Derivatives designated as hedges: | | | | | | | | | | Cash flow hedge | | Operating expenses | | $ | (3,443) | | | $ | (1,312) | | | $ | (3,702) | | | Net investment hedge | | Interest and other related expense, net | | 3,300 | | | 3,707 | | | 1,344 | | | | | | | | | | | | Derivatives not designated as hedges: | | | | | | | | | | Deal-contingent forward contract | | Other income (expense), net | | — | | | — | | | 9,354 | | | Non-contingent forward contract | | Other income (expense), net | | — | | | — | | | 9,052 | | | Cross currency swap contracts | | Other income (expense), net | | (54,666) | | | 3,116 | | | (9,779) | | | Cross currency swap contracts | | Interest and other related expense, net | | 2,842 | | | 3,441 | | | 1,421 | | | Total | | | | $ | (51,967) | | | $ | 8,952 | | | $ | 7,690 | |
|
| Schedule of Effects of the Cash Flow and Net Investment Hedges |
The effects of the cash flow and net investment hedges on our Consolidated Statements of Comprehensive Income: | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | Consolidated Statements of Income and Consolidated Statements of Comprehensive Income Location | | 2025 | | 2024 | | 2023 | | Gain (loss) recognized in OCI (loss) on cash flow hedge (effective portion) | Unrealized gain (loss) on cash flow hedge | | $ | (548) | | | $ | (3,670) | | | $ | (1,280) | | | Gain (loss) recognized in OCI (loss) on net investment hedge (effective portion) | Net foreign currency translation adjustment | | (73,060) | | | (331) | | | (32,347) | | | Gain (loss) reclassified from AOCI into income (effective portion) - cash flow hedge | Operating expenses | | (3,443) | | | (1,312) | | | (3,702) | | | Gain (loss) reclassified from AOCI into income (excluded from effectiveness testing) - net investment hedge | Interest and other related expense, net | | 2,244 | | | 2,244 | | | 748 | |
|